Comparison of Daclatasvir Resistance Barriers on NS5A from Hepatitis C Virus Genotypes 1 to 6: Implications for Cross-Genotype Activity
出版年份 2014 全文链接
标题
Comparison of Daclatasvir Resistance Barriers on NS5A from Hepatitis C Virus Genotypes 1 to 6: Implications for Cross-Genotype Activity
作者
关键词
-
出版物
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 58, Issue 9, Pages 5155-5163
出版商
American Society for Microbiology
发表日期
2014-06-17
DOI
10.1128/aac.02788-14
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
- (2014) Mark S. Sulkowski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA
- (2014) David B. Ascher et al. Scientific Reports
- Persistence of Resistant Variants in Hepatitis C Virus-Infected Patients Treated with the NS5A Replication Complex Inhibitor Daclatasvir
- (2013) Chunfu Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Differential Sensitivity of 5′UTR-NS5A Recombinants of Hepatitis C Virus Genotypes 1−6 to Protease and NS5A Inhibitors
- (2013) Yi-Ping Li et al. GASTROENTEROLOGY
- Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir
- (2013) Fiona McPhee et al. HEPATOLOGY
- A 96-well based analysis of replicon elimination with the HCV NS5A replication complex inhibitor daclatasvir
- (2013) Donald R. O’Boyle et al. JOURNAL OF VIROLOGICAL METHODS
- Characterizations of HCV NS5A replication complex inhibitors
- (2013) Donald R. O'Boyle II et al. VIROLOGY
- In VitroActivity of Daclatasvir on Hepatitis C Virus Genotype 3 NS5A
- (2012) Chunfu Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants
- (2012) Vincenzo Summa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hepatitis C Virus RNA Elimination and Development of Resistance in Replicon Cells Treated with BMS-790052
- (2012) Chunfu Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combination Treatment with Hepatitis C Virus Protease and NS5A Inhibitors Is Effective against Recombinant Genotype 1a, 2a, and 3a Viruses
- (2012) Judith M. Gottwein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of a baseline polymorphism on the emergence of resistance to the hepatitis C virus nonstructural protein 5a replication complex inhibitor, BMS-790052
- (2012) Jin-Hua Sun et al. HEPATOLOGY
- Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial
- (2012) Stanislas Pol et al. LANCET INFECTIOUS DISEASES
- Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
- (2012) Anna S. Lok et al. NEW ENGLAND JOURNAL OF MEDICINE
- In VitroActivity of BMS-790052 on Hepatitis C Virus Genotype 4 NS5A
- (2011) Chunfu Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1
- (2011) Richard E. Nettles et al. HEPATOLOGY
- Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations
- (2011) Robert A. Fridell et al. HEPATOLOGY
- Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders
- (2011) Kazuaki Chayama et al. HEPATOLOGY
- Distinct Functions of NS5A in Hepatitis C Virus RNA Replication Uncovered by Studies with the NS5A Inhibitor BMS-790052
- (2011) R. A. Fridell et al. JOURNAL OF VIROLOGY
- Small Molecules Targeting Hepatitis C Virus-Encoded NS5A Cause Subcellular Redistribution of Their Target: Insights into Compound Modes of Action
- (2011) P. Targett-Adams et al. JOURNAL OF VIROLOGY
- Resistance Analysis of the Hepatitis C Virus NS5A Inhibitor BMS-790052 in an In Vitro Replicon System
- (2010) R. A. Fridell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recombinant HCV Variants With NS5A From Genotypes 1–7 Have Different Sensitivities to an NS5A Inhibitor but Not Interferon-α
- (2010) Troels K.H. Scheel et al. GASTROENTEROLOGY
- A perspective on modelling hepatitis C virus infection
- (2010) J. Guedj et al. JOURNAL OF VIRAL HEPATITIS
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
- (2010) Min Gao et al. NATURE
- Identification of Hepatitis C Virus NS5A Inhibitors
- (2009) J. A. Lemm et al. JOURNAL OF VIROLOGY
- Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
- (2009) J. M. Cuevas et al. JOURNAL OF VIROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started